Figure 1 HLA-haploidentical donors

Slides:



Advertisements
Similar presentations
Immune system, Organ Transplants and Blood Chapter 13.
Advertisements

Principles of Immunology Major Histocompatibility Complex 2/28/06 “Change is not merely necessary for life. It is life.” A Toffler.
The Chemosensory Recognition of Genetic Individuality Beauchamp, Yamazaki and Boyse.
HLA TYPING D Middleton MDSC175: Transplantation Science for Transplant Clinicians (Online) POSTGRADUATE SCHOOL OF MEDICINE A MEMBER OF THE RUSSELL GROUP.
Bone Marrow Transplantation. Unlike solid organ transplant, in bone marrow transplantation (BMT) the immunology goes two ways. There is host vs. ​ graft.
Medical Interventions
Tissue Typing. E VERYONE HAS SEVERAL ANTIGENS LOCATED ON THE SURFACE OF HIS / HER LEUKOCYTES : One particular group of these antigens is called the HLA.
Transplantation immunology Dr Adel Almogren.. Transfusion vs. Transplantation  Transfusion  transfer of blood  Ab-mediated reactions  Transplantation.
The genetic bases BY Casey Jaroche
11 22 33  m 11 22 33 11 22 11 22 Classical MHC I human MICA, B ULBP-human RAE-1- like human NKG2D-ligands mouse NKG2D-ligands RAE-1,
IMMUNOGENETIC TESTS.
Lesson Overview Lesson Overview Human Chromosomes Lesson Overview 14.1 Human Chromosomes.
Major Histocompatibility Complex and Transplantation Major histocompatibility complex (MHC) proteins were discovered for the first time with the advent.
Transplantation Immunology Unit College of Medicine
HAPLOIDENTICAL STEM CELL TRANSPLANT
Copyright © 2001 American Medical Association. All rights reserved.
Transplantation Immunology Unit College of Medicine
Transplantation Immunology Unit College of Medicine
Transplantation Pathology
DNA Analysis of the HLA Gene Complex
HLA Linkage vs Association in Hypertrophic Cardiomyopathy
Supplemental table 1 Patients' characteristics Variables Number
Figure 2 Underreporting by physicians of specific treatment-associated symptoms by physicians in the TORCH trial Figure 2 | Underreporting by physicians.
Figure 5 Mutational heterogeneity in oesophageal and gastric cancer
Major Histocompatibility complex OR
Figure 5 Schematic illustration of different clinical trial designs
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Molecular Typing Shows a High Level of HLA Class I Incompatibility in Serologically Well Matched Donor/Patient Pairs: Implications for Unrelated Bone Marrow.
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 2 Copy-number variations in multiple myeloma
Figure 5 Identification of mucinous carcinoma
Pedigrees Pedigree charts show a record of the family of an individual. It can be used to study the transmission of a hereditary condition (genetic disease).
Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.
Figure 1 Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced-stage lung cancer, or early-stage breast.
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 1 CAR-T-cell design
First systematic experience of preimplantation genetic diagnosis for de-novo mutations  Svetlana Rechitsky, Ekaterina Pomerantseva, Tatiana Pakhalchuk,
Nat. Rev. Clin. Oncol. doi: /nrclinonc
ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION for MULTIPLE MYELOMA
Figure 3 Possible modalities for reconciliation of patient's and physician's report of symptomatic treatment-associated toxicities Figure 3 | Possible.
chemotherapy for patients with MC versus those with AC
Figure 3 Structure of different types of T-cell-engaging antibodies
Figure 3 Summary of overall survival by Kaplan–Meier
Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease.
Figure 2 Components of each transplantation platform
Figure 3 Clinical trial design in charged-particle therapy (CPT)
Noninherited Maternal Antigens Identify Acceptable HLA Mismatches: Benefit to Patients and Cost-Effectiveness for Cord Blood Banks  Henk G.M. Van der.
Figure 1 Translocations involved in multiple myeloma
Dynamic Detection of Anti–Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall.
Donor Selection in T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation: Knowns, Unknowns, and Controversies  Stefan O. Ciurea, Richard.
Higher CD34+ and CD3+ Cell Doses in the Graft Promote Long-Term Survival, and Have No Impact on the Incidence of Severe Acute or Chronic Graft-versus-Host.
Genetic studies into inherited and sporadic hemolytic uremic syndrome
Figure 5 Schematic overview of a clinical decision-support
A Recurrent Expansion of a Maternal Allele with 36 CAG Repeats Causes Huntington Disease in Two Sisters  Franco Laccone, Wilhelm Christian  The American.
Germ-Line Mosaicism in Tuberous Sclerosis: How Common?
Impact of HLA-DPB1 Haplotypes on Outcome of 10/10 Matched Unrelated Hematopoietic Stem Cell Donor Transplants Depends on MHC-Linked Microsatellite Polymorphisms 
Improved Survival with Inhibitory Killer Immunoglobulin Receptor (KIR) Gene Mismatches and KIR Haplotype B Donors after Nonmyeloablative, HLA-Haploidentical.
A Severely Affected Male Born into a Rett Syndrome Kindred Supports X-Linked Inheritance and Allows Extension of the Exclusion Map  Carolyn Schanen, Uta.
HLA-Mismatched, Noninherited Maternal Antigen–Matched Unrelated Cord Blood Transplantations Have Superior Survival: How HLA Typing the Cord Blood Donor's.
Figure 4 Radiogenomics analysis can reveal relationships
Figure 1 Overview of the imaging biomarker roadmap
Young Female Donors Do Not Increase the Risk of Graft-versus-Host Disease or Impact Overall Outcomes in Pediatric HLA-Matched Sibling Hematopoietic Stem.
Figure 1 Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and patients with frontotemporal dementia Mutated CTSF in adult-onset neuronal ceroid.
Figure 3 Determination of the primary site
Constitutional Mutations of the hSNF5/INI1 Gene Predispose to a Variety of Cancers  Nicolas Sévenet, Eammon Sheridan, Daniel Amram, Pascale Schneider,
A Gene for an Autosomal Dominant Scleroatrophic Syndrome Predisposing to Skin Cancer (Huriez Syndrome) Maps to Chromosome 4q23  Young-Ae Lee, Howard P.
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Presentation transcript:

Figure 1 HLA-haploidentical donors Figure 1 | HLA-haploidentical donors. a | Located on the short arm of chromosome 6, the HLA region contains the genes for class I and class II histocompatibility molecules, which are commonly tested as clinically relevant transplantation antigens. However, the HLA region is genetically complex and includes other class I and class II genes in addition to genes not involved in histocompatibility (not shown). b | An example pedigree is shown. The patient in this pedigree does not have an HLA-matched sibling, although she has four HLA-haploidentical family members. Each individual haplotype is denoted by a lower-case letter above it. Note that the term HLA-haploidentical simply denotes the presence of one shared haplotype and one unshared haplotype between the patient and her potential donors; a 'haplo' donor can be more than 'half-matched' if there are common alleles on the unshared haplotypes. HVG and GVH indicate the degree of matching in the host-versus-graft and graft-versus-host directions, respectively. Mismatching at non-inherited maternal or non-inherited paternal antigens, which also might affect the relative antigenicity of the donor:recipient pair, are indicated for the 'haplo' siblings. Abbreviations: GVH, graft-versus-host; HLA, human leukocyte antigen; HVG, host-versus-graft; NIMA, non-inherited maternal antigens; NIPA, non-inherited paternal antigens. Kanakry, C. G. et al. (2015) Modern approaches to HLA-haploidentical blood or marrow transplantation Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2015.128